Ticker Details
Immunocore Holdings
IPO Date:	February 5, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.67B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.01 | 2.44%
Avg Daily Range (30 D):	$0.62 | 1.88%
Avg Daily Range (90 D):	$0.67 | 1.94%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.42M
Avg Daily Volume (90 D):	.34M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	90
Avg Trade Size (Sh.) (90 D):	82

Institutional Trades
Total Institutional Trades:	1,905
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.28M
Avg Institutional Trade (90 D):	$1.17M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$.8M
Avg Closing Trade (90 D):	$.79M
Avg Closing Volume:	34.87K

News

Mar 3, 2026 @ 12:00 PM Immunocore to present at upcoming investor confere... Source: Na

Feb 18, 2026 @ 12:00 PM Immunocore to report fourth quarter and full year ... Source: Na

Jan 30, 2026 @ 12:00 PM Immunocore announces R&D leadership evolution Source: Not Specified

Nov 7, 2025 @ 1:00 PM Immunocore presents Phase 1 data for hepatitis B c... Source: Immunocore Holdings Plc

Oct 30, 2025 @ 3:15 PM Growth Picks: 3 Low-Cost Stocks That Could Double ... Source: Chris Markoch

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.71	$-.6	$-.71
Diluted EPS	$-.71	$-.6	$-.71
Revenue	$400.02M	$104.48M	$400.02M
Gross Profit	$394.93M	$101.78M	$394.93M
Net Income / Loss	$-35.51M	$-30.06M	$-35.51M
Operating Income / Loss	$-45.35M	$-19.69M	$-45.35M
Cost of Revenue	$5.09M	$2.7M	$5.09M
Net Cash Flow	$11.98M	$-30.7M	$11.98M
PE Ratio